Table of Contents
ASCO/FDA Public Workshop onClinical Trials Endpoints inColorectal Cancer
Evolution of Adjuvant Treatment
Proposed Rectal Cancer Endpoints
Local-Regional Failure
Local-Regional Failure Characteristics
Post-Op ChemoRT vs Surgery
Post-Op ChemoRT vs Single Modality
Short-Term Pre-Op Radiotherapy vs Surgery Alone
Pre-Op vs Post-Op Chemoradiation
German Trial – CAO/ARO/AIO-94
Pathologic Complete Response
Pathologic Assessment: # Lymph Nodes & Outcome
Future US Phase III Trials:Rectal Cancer
PPT Slide
Rectal Cancer EndpointsNeoadjuvant Therapy-Stage II/III Rectal Cancer
|